🅇
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient.
Status
Recruiting
Phase
N/A
NCT ID
NCT05839418
Trial Summary
SENSE-II/AROUSE is a prospective, multicenter registry for patients treated for SE. The primary objective is to document patients and SE characteristics, treatment modalities, EEG features, and outcome of consecutive adults admitted fir SE treatment in each of the participating centers and to identify predictors of outcome and refractoriness.
Sponsor: Erasme University Hospital
Participants: ALL
Start: 2023-03-01
Completion: 2028-12-31
Min Age: 18 Years
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 years or above * Patients admitted for management of Status Epilepticus as their primary diagnosis * Patients admitted for another primary diagnosis but identified with Status Epilepticus during their acute hospital stay Exclusion Criteria: – Patients with post-cardiac arrest SE
Data from ClinicalTrials.gov. Always verify on the primary source before clinical use.